2025
SJR Q2
JCR Q2 · 2,2
52 matched articles
SCIE
Journal detail
Histology and Histopathology
- Publisher
- Histology and Histopathology
- Country
- Spain · Western Europe
- Type
- journal
- ISSN
-
0213391116995848
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,596
- Quartile Q2
- H-Index 108
- Cites/doc 2,13
- Docs (3y) 373
- Cites (3y) 864
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 2,2
- 5Y JIF 2,2
- JCI 0,56
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Histology Q2
- Pathology and Forensic Medicine Q2
Areas
- Medicine
WoS categories
- Cell Biology | Pathology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q2 | 0,596 | 2,2 | 2,2 | 0,56 | Q3 | 108 |
| 2024 | Q2 | Q2 | 0,649 | 2 | 2 | 0,58 | Q3 | 106 |
| 2023 | Q2 | Q2 | 0,571 | 2,5 | 1,9 | 0,49 | Q3 | 106 |
| 2022 | Q2 | Q3 | 0,47 | 2 | 1,9 | 0,41 | Q3 | 106 |
| 2021 | Q2 | Q3 | 0,513 | 2,1 | 2,2 | 0,42 | Q3 | 106 |
| 2020 | Q2 | Q3 | 0,628 | 2,3 | 2,1 | 0,46 | Q3 | 106 |
| 2019 | Q2 | Q3 | 0,625 | 2 | 1,8 | 0,51 | Q3 | 106 |
| 2018 | — | Q3 | — | 1,8 | 1,7 | 0,49 | Q3 | — |
| 2017 | Q2 | Q3 | 0,672 | 2 | 1,8 | 0,48 | Q3 | 106 |
| 2016 | Q2 | Q2 | 0,722 | 2 | 1,9 | — | — | 106 |
| 2015 | Q2 | Q3 | 0,821 | 1,9 | 2,1 | — | — | 106 |
| 2014 | Q2 | Q2 | 0,891 | 2,1 | 2,1 | — | — | 106 |
| 2013 | Q1 | Q2 | 1,095 | 2,2 | 2,3 | — | — | 106 |
| 2012 | Q1 | Q2 | 1,027 | 2,3 | 2,2 | — | — | 106 |
| 2011 | Q1 | Q2 | 1,049 | 2,5 | 2,1 | — | — | 106 |
| 2010 | Q1 | Q2 | 0,936 | 2,5 | 2,2 | — | — | 106 |
| 2009 | — | Q2 | — | 2,4 | 2,1 | — | — | — |
| 2008 | — | Q2 | — | 2,2 | 1,9 | — | — | — |
| 2007 | — | Q2 | — | 2 | 1,9 | — | — | — |
| 2006 | — | Q2 | — | 2,2 | — | — | — | — |
| 2005 | — | Q2 | — | 2 | — | — | — | — |
| 2004 | — | Q2 | — | 1,9 | — | — | — | — |
| 2003 | — | Q2 | — | 1,8 | — | — | — | — |
| 2002 | — | Q2 | — | 1,9 | — | — | — | — |
| 2001 | — | Q2 | — | 1,9 | — | — | — | — |
| 2000 | — | Q2 | — | 1,6 | — | — | — | — |
| 1999 | — | Q2 | — | 1,6 | — | — | — | — |
| 1998 | — | Q2 | — | 1,4 | — | — | — | — |
| 1997 | — | Q2 | — | 1 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | CELL BIOLOGY | SCIE | Q4 | Q3 | 165/207 |
| 2025 | PATHOLOGY | SCIE | Q2 | Q3 | 44/89 |
| 2024 | CELL BIOLOGY | SCIE | Q4 | Q3 | 168/204 |
| 2024 | PATHOLOGY | SCIE | Q2 | Q3 | 45/90 |
| 2023 | CELL BIOLOGY | SCIE | Q3 | Q3 | 148/205 |
| 2023 | PATHOLOGY | SCIE | Q2 | Q3 | 37/88 |
| 2022 | CELL BIOLOGY | SCIE | Q4 | Q4 | 171/191 |
| 2022 | PATHOLOGY | SCIE | Q3 | Q3 | 47/76 |
| 2021 | CELL BIOLOGY | SCIE | Q4 | Q4 | 174/195 |
| 2021 | PATHOLOGY | SCIE | Q3 | Q3 | 52/77 |
| 2020 | CELL BIOLOGY | SCIE | Q4 | Q4 | 163/195 |
| 2020 | PATHOLOGY | SCIE | Q3 | Q3 | 46/77 |
| 2019 | CELL BIOLOGY | SCIE | Q4 | Q3 | 157/195 |
| 2019 | PATHOLOGY | SCIE | Q3 | Q3 | 44/78 |
| 2018 | CELL BIOLOGY | SCIE | Q4 | Q3 | 163/193 |
| 2018 | PATHOLOGY | SCIE | Q3 | Q3 | 47/76 |
| 2017 | CELL BIOLOGY | SCIE | Q4 | Q3 | 152/190 |
| 2017 | PATHOLOGY | SCIE | Q3 | Q3 | 40/79 |
| 2016 | CELL BIOLOGY | SCIE | Q4 | — | 145/190 |
| 2016 | PATHOLOGY | SCIE | Q2 | — | 35/79 |
| 2015 | CELL BIOLOGY | SCIE | Q4 | — | 148/187 |
| 2015 | PATHOLOGY | SCIE | Q3 | — | 40/79 |
| 2014 | CELL BIOLOGY | SCIE | Q3 | — | 138/184 |
| 2014 | PATHOLOGY | SCIE | Q2 | — | 34/76 |
| 2013 | CELL BIOLOGY | SCIE | Q3 | — | 131/185 |
| 2013 | PATHOLOGY | SCIE | Q2 | — | 34/76 |
| 2012 | CELL BIOLOGY | SCIE | Q3 | — | 128/185 |
| 2012 | PATHOLOGY | SCIE | Q2 | — | 30/77 |
| 2011 | CELL BIOLOGY | SCIE | Q3 | — | 120/181 |
| 2011 | PATHOLOGY | SCIE | Q2 | — | 29/79 |
| 2010 | CELL BIOLOGY | SCIE | Q3 | — | 111/178 |
| 2010 | PATHOLOGY | SCIE | Q2 | — | 25/76 |
| 2009 | CELL BIOLOGY | SCIE | Q3 | — | 103/162 |
| 2009 | PATHOLOGY | SCIE | Q2 | — | 27/71 |
| 2008 | CELL BIOLOGY | SCIE | Q3 | — | 106/157 |
| 2008 | PATHOLOGY | SCIE | Q2 | — | 30/69 |
| 2007 | CELL BIOLOGY | SCIE | Q3 | — | 106/156 |
| 2007 | PATHOLOGY | SCIE | Q2 | — | 26/66 |
| 2006 | CELL BIOLOGY | SCIE | Q3 | — | 100/156 |
| 2006 | PATHOLOGY | SCIE | Q2 | — | 25/64 |
| 2005 | CELL BIOLOGY | SCIE | Q3 | — | 98/153 |
| 2005 | PATHOLOGY | SCIE | Q2 | — | 27/66 |
| 2004 | CELL BIOLOGY | SCIE | Q3 | — | 101/155 |
| 2004 | PATHOLOGY | SCIE | Q2 | — | 21/65 |
| 2003 | CELL BIOLOGY | SCIE | Q3 | — | 95/156 |
| 2003 | PATHOLOGY | SCIE | Q2 | — | 25/64 |
| 2002 | CELL BIOLOGY | SCIE | Q3 | — | 88/153 |
| 2002 | PATHOLOGY | SCIE | Q2 | — | 24/64 |
| 2001 | CELL BIOLOGY | SCIE | Q3 | — | 84/147 |
| 2001 | PATHOLOGY | SCIE | Q2 | — | 19/66 |
| 2000 | CELL BIOLOGY | SCIE | Q3 | — | 93/147 |
| 2000 | PATHOLOGY | SCIE | Q2 | — | 22/67 |
| 1999 | CELL BIOLOGY | SCIE | Q3 | — | 83/141 |
| 1999 | PATHOLOGY | SCIE | Q2 | — | 22/66 |
| 1998 | CELL BIOLOGY | SCIE | Q3 | — | 87/139 |
| 1998 | PATHOLOGY | SCIE | Q2 | — | 23/68 |
| 1997 | CELL BIOLOGY | SCIE | Q3 | — | 97/130 |
| 1997 | PATHOLOGY | SCIE | Q2 | — | 33/66 |